Haleon plc (NYSE:HLN) Receives Average Recommendation of “Moderate Buy” from Analysts

Haleon plc (NYSE:HLN) has earned a consensus rating of “Moderate Buy” from the seven brokerages that are presently covering the stock, MarketBeat reports. Three research analysts have rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the company. The average 1 year target price among brokerages that have issued a report on the stock in the last year is $10.95.

HLN has been the subject of several research reports. UBS Group raised shares of Haleon to a “strong-buy” rating in a report on Tuesday, October 1st. Morgan Stanley lowered Haleon from an “overweight” rating to an “equal weight” rating in a report on Friday, January 10th. Finally, Sanford C. Bernstein downgraded Haleon from an “outperform” rating to a “market perform” rating in a report on Wednesday, January 8th.

Haleon Stock Performance

Haleon stock opened at $9.12 on Friday. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.84 and a quick ratio of 0.58. Haleon has a 12 month low of $7.89 and a 12 month high of $10.80. The company has a fifty day moving average price of $9.56 and a two-hundred day moving average price of $9.69. The company has a market cap of $41.28 billion, a PE ratio of 26.82, a P/E/G ratio of 2.95 and a beta of 0.29.

Institutional Investors Weigh In On Haleon

Several large investors have recently made changes to their positions in the company. FMR LLC grew its holdings in Haleon by 5.8% in the 3rd quarter. FMR LLC now owns 104,918,269 shares of the company’s stock worth $1,110,035,000 after buying an additional 5,768,117 shares in the last quarter. Clearbridge Investments LLC boosted its position in Haleon by 8.6% during the 2nd quarter. Clearbridge Investments LLC now owns 41,753,987 shares of the company’s stock worth $344,888,000 after acquiring an additional 3,307,009 shares during the period. Wellington Management Group LLP grew its stake in shares of Haleon by 49.9% in the third quarter. Wellington Management Group LLP now owns 9,152,490 shares of the company’s stock worth $96,833,000 after purchasing an additional 3,046,841 shares in the last quarter. Sculptor Capital LP grew its stake in shares of Haleon by 67.8% in the second quarter. Sculptor Capital LP now owns 8,887,098 shares of the company’s stock worth $73,407,000 after purchasing an additional 3,592,000 shares in the last quarter. Finally, Douglas Lane & Associates LLC raised its stake in shares of Haleon by 1.9% during the fourth quarter. Douglas Lane & Associates LLC now owns 8,624,149 shares of the company’s stock valued at $82,274,000 after purchasing an additional 161,865 shares in the last quarter. Institutional investors and hedge funds own 6.67% of the company’s stock.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.